The Clinical Trials platform supports the implementation of clinical trials, helping researchers engage in high-quality, practice changing, patient-oriented research. Services include support for industry-sponsored clinical trials, investigator-initiated trials and epidemiological studies led by Manitoba researchers. The platform also promotes a streamlined research process to increase the number of clinical trials in Manitoba, which will translate to evidence-informed improvements in our health-care system.
Our team of epidemiologists, experienced clinical trial research staff, and IT support offers consultation in such areas as:
- Health Canada submission (CTA) support
- Clinical trial registration and results reporting support
- Development of safety plans (monitoring plan, DSMB charter) and case report forms
- Protocol development
- Scientific review of clinical trial methods - grants, manuscript preparation, pre-REB review
- Mobile app development
- Clinical trial management software development and training
- Good Clinical Practice and Health Canada Division 5 training for scientists and study staff
Salah Mahmud is a clinician, public health physician and epidemiologist with interest in drug and vaccine development and evaluation. He is a Canada Research chair in Pharmaco-epidemiology and Vaccine Evaluation, the founding director of VDEC, the founding director of the Clinical Trials Platform of the Manitoba CIHR SUPPORT Unit and Clinician Researcher, Population & Public Health, Manitoba Health. He currently holds an appointment as an Associate Professor of Community Health Sciences and Pharmacy in the Rady College of Medicine, University of Manitoba, serves as the Associate Editor of Preventive Medicine and as a member of several national and international committees and advisory boards related to vaccine policy and development.
Director, Clinical Trials Platform
Tarpan Mankad, M.Sc. (Clinical Research); Diploma (Project Management)
Clinical Trial Specialist
*Now accepting students*
Dr Protudjer’s primary research focus is risk factors, management, impact and prognosis of paediatric allergic disease. She has experience using national register/healthcare administrative data, covering >99% of the population, as well as experience with cohorts of various sizes. Many of these cohorts have included clinical data, from which more rigorous definitions of disease outcomes may be identified.
To complement these quantitative data, Dr Protudjer also engages in qualitative research, so as to better understand the needs and impact of paediatric allergic disease on the child, their family and those who help care for them.
The cumulative aim of her work is to develop patient-oriented programs, which engage a variety of stakeholders to provide a multifaceted approach that fully support patients’ needs.
As a nutritionist, Dr Protudjer also has a strong interest on maternal and child diets, and their roles in child health, and paediatric chronic diseases.
Dr Protudjer maintains collaborations in Manitoba, in Canada, as well as in Sweden and Finland.
Epidemiologist, CHI; Assistant Professor, Department of Pediatrics and Child Health, University of Manitoba; Scientist, Children's Hospital Research Institute of Manitoba
tel: 204 594 5356
Dr. Kelly has a PhD in Pharmacology, completed two post-doctoral fellowships at the Hospital for Sick Children and Mount Sinai Hospital and is a Certified Clinical Research Professional. Lauren is an Assistant Professor in Pediatrics & Child Health at the University of Manitoba and has been working in pediatric clinical research since 2008. Dr. Kelly has published more than 20 peer reviewed articles and is a reviewer with Cochrane Neonatal Review Group. Her research focus on clinical trial methodology, pediatric and neonatal opioid response, systematic reviews and education.
Clinical Trialist, Assistant Professor Deptartments of Pediatrics and Child Health and Community Health Sciences
Dr. MacKay has a PhD in Human Nutritional Sciences and is an Assistant Professor in the Department of Community Health Sciences at the University of Manitoba. Dylan is a nutritional biochemist, specializing in human clinical trials and inter-individual variability. He is interested in the appropriate design and implementation of human clinical trials, especially in the field of human nutrition. His research is broadly focused on how lifestyle can impact chronic disease risk and whether lifestyle intervention strategies can be made more effective through personalization. Dylan is also very interested in how to appropriately translate scientific findings to combat misinformation, especially on the internet and social media.